Details for New Drug Application (NDA): 205761
✉ Email this page to a colleague
The generic ingredient in RABEPRAZOLE SODIUM is rabeprazole sodium. There are thirty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the rabeprazole sodium profile page.
Summary for 205761
Tradename: | RABEPRAZOLE SODIUM |
Applicant: | Aurobindo Pharma |
Ingredient: | rabeprazole sodium |
Patents: | 0 |
Pharmacology for NDA: 205761
Mechanism of Action | Proton Pump Inhibitors |
Medical Subject Heading (MeSH) Categories for 205761
Suppliers and Packaging for NDA: 205761
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 205761 | ANDA | Aurobindo Pharma Limited | 65862-721 | 65862-721-30 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (65862-721-30) |
RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 205761 | ANDA | Aurobindo Pharma Limited | 65862-721 | 65862-721-90 | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (65862-721-90) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 20MG | ||||
Approval Date: | Feb 17, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription